{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:32:59Z","timestamp":1794313979267,"version":"4.9.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"am","delay-in-days":272,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020523","name":"US Drug Enforcement Administration","doi-asserted-by":"publisher","award":["15DDHQ19A00000010"],"award-info":[{"award-number":["15DDHQ19A00000010"]}],"id":[{"id":"10.13039\/100020523","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007646","name":"Department of Environmental Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AT-010773"],"award-info":[{"award-number":["R01 AT-010773"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K01 DA-045752"],"award-info":[{"award-number":["K01 DA-045752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.pnpbp.2024.110984","type":"journal-article","created":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T23:06:35Z","timestamp":1708988795000},"page":"110984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice"],"prefix":"10.1016","volume":"132","author":[{"given":"Jenny L.","family":"Wiley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Marusich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Blough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ojas","family":"Namjoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Brackeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luli R.","family":"Akinfiresoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teneille D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Prioleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Barrus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Gamage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.110984_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0149-7634(05)80051-X","article-title":"\u22069-tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication","volume":"16","author":"Balster","year":"1992","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"13","key":"10.1016\/j.pnpbp.2024.110984_bb0010","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1016\/0040-4020(95)00104-G","article-title":"Stereochemistry of 14-hydroxy-\u03b2-caryophyllene and related compounds","volume":"51","author":"Barrero","year":"1995","journal-title":"Tetrahedron"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110984_bb0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF02245942","article-title":"Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats","volume":"118","author":"Barrett","year":"1995","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110984_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: pharmacology and therapeutic targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110984_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00421108","article-title":"Delta 9-tetrahydrocannabinol, ethanol, and amphetamine as discriminative stimuli-generalization tests with other drugs","volume":"46","author":"Bueno","year":"1976","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pnpbp.2024.110984_bb0030","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3565(25)38122-X","article-title":"Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities","volume":"265","author":"Compton","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0035","series-title":"Method For Extraction of Cannabinoids and Synthesis of THC To CBN","author":"D'Spain","year":"2022"},{"key":"10.1016\/j.pnpbp.2024.110984_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3389\/fphar.2020.00359","article-title":"Terpenoids from Cannabis do not mediate an entourage effect by acting at cannabinoid receptors","volume":"11","author":"Finlay","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0045","series-title":"Guidance for Industry: Assessment of Abuse Potential of Drugs","author":"Food and Drug Administration","year":"2010"},{"key":"10.1016\/j.pnpbp.2024.110984_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104801","article-title":"Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids","volume":"158","author":"Franco","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172918","article-title":"In vitro and in vivo pharmacological evaluation of the synthetic cannabinoid receptor agonist EG-018","volume":"193","author":"Gamage","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"26","key":"10.1016\/j.pnpbp.2024.110984_bb0060","doi-asserted-by":"crossref","first-page":"9099","DOI":"10.1073\/pnas.0803601105","article-title":"Beta-caryophyllene is a dietary cannabinoid","volume":"105","author":"Gertsch","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000136462","article-title":"Structure-activity relationships in man of cannabis constituents, and homologs and metabolites of \u03949-THC","volume":"11","author":"Hollister","year":"1974","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.pnpbp.2024.110984_bb0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/cpt196896783","article-title":"Comparison of tetrahydrocannabinol and synhexl in man","volume":"9","author":"Hollister","year":"1968","journal-title":"Clin. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110984_bb0080","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1007\/s00044-014-0972-6","article-title":"Evaluation of Phytocannabinoids from high potency Cannabis sativa using in vitro bioassays to determine structure-activity relationships for cannabinoid receptor 1 and cannabinoid receptor 2","volume":"23","author":"Husni","year":"2014","journal-title":"Med. Chem. Res."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2024.110984_bb0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0028-3908(87)90212-7","article-title":"Cannabimimetic activity of cannabinol in rats and pigeons","volume":"26","author":"J\u00e4rbe","year":"1987","journal-title":"Neuropharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110984_bb0090","first-page":"68","article-title":"Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN","volume":"228","author":"J\u00e4rbe","year":"1977","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"issue":"25","key":"10.1016\/j.pnpbp.2024.110984_bb0095","doi-asserted-by":"crossref","first-page":"13581","DOI":"10.1021\/jacs.3c00129","article-title":"Axially chiral cannabinoids: design, synthesis, and cannabinoid receptor affinity","volume":"145","author":"Kearney","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0100","doi-asserted-by":"crossref","unstructured":"Koppel, B.S., Brust, J.C., Fife, T., Bronstein, J., Youssof, S., Gronseth, G., Gloss, D., 2014. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the guideline development Subcommittee of the American Academy of neurology. Neurology 82(17), 1556\u20131563.","DOI":"10.1212\/WNL.0000000000000363"},{"issue":"20","key":"10.1016\/j.pnpbp.2024.110984_bb0105","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1021\/jm0001572","article-title":"Novel cannabinol probes for CB1 and CB2 cannabinoid receptors","volume":"43","author":"Mahadevan","year":"2000","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.pnpbp.2024.110984_bb0110","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/sj.bjp.0707399","article-title":"Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences","volume":"152","author":"McPartland","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/cpns.31","article-title":"Cannabinoid-induced tetrad in mice","volume":"80","author":"Metna-Laurent","year":"2017","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0120","series-title":"Guide for the Care and Use of Laboratory Animals National Academies Press","author":"National Research Council","year":"2011"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110984_bb0125","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/BF01922823","article-title":"A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol","volume":"29","author":"Perez-Reyes","year":"1973","journal-title":"Experientia"},{"issue":"5","key":"10.1016\/j.pnpbp.2024.110984_bb0130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.bjp.0707124","article-title":"The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo","volume":"150","author":"Pertwee","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0135","series-title":"Synthesis of Phytocannabinoids Including a Decarboxylation Step","author":"Reekie","year":"2019"},{"key":"10.1016\/j.pnpbp.2024.110984_bb0140","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ntt.2014.09.003","article-title":"Differences in receptor binding affinity of several phytocannabinoids do not explain their effects on neural cell cultures","volume":"46","author":"Rosenthaler","year":"2014","journal-title":"Neurotoxicol. Teratol."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110984_bb0145","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110984_bb0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/can.2019.0016","article-title":"Absence of entourage: Terpenoids commonly found in Cannabis sativa do not modulate the functional activity of \u0394(9)-THC at human CB(1) and CB(2) receptors","volume":"4","author":"Santiago","year":"2019","journal-title":"Cannabis and Cannabinoid Res."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110984_bb0155","first-page":"Cd009464","article-title":"Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy","volume":"2015","author":"Smith","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"15","key":"10.1016\/j.pnpbp.2024.110984_bb0160","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1111\/bph.15865","article-title":"Review of delta-8-tetrahydrocannabinol (\u0394(8) -THC): comparative pharmacology with \u0394(9) -THC","volume":"179","author":"Tagen","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110984_bb0165","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","article-title":"Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist","volume":"146","author":"Thomas","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"099868","key":"10.1016\/j.pnpbp.2024.110984_bb0170","first-page":"A1","article-title":"Process for the preparation of (\u2212) -delta 9-tetrahydrocannabinol","volume":"2009","author":"Trawick","year":"2009","journal-title":"World Intellectual Property Organization Patent WO"},{"key":"10.1016\/j.pnpbp.2024.110984_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109640","article-title":"Assessment of dependence potential and abuse liability of \u0394(8)-tetrahydrocannabinol in mice","volume":"240","author":"Vanegas","year":"2022","journal-title":"Drug Alcohol Depend."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2024.110984_bb0180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.drugalcdep.2007.11.017","article-title":"Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol","volume":"94","author":"Vann","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2024.110984_bb0185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2009.05.010","article-title":"Discriminative stimulus properties of delta9-tetrahydrocannabinol (THC) in C57Bl\/6J mice","volume":"615","author":"Vann","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.pnpbp.2024.110984_bb0190","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and Meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110984_bb0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(03)01856-9","article-title":"Cannabinoid pharmacological properties common to other centrally acting drugs","volume":"471","author":"Wiley","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110984_bb0200","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0376-8716(95)01193-5","article-title":"Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys","volume":"40","author":"Wiley","year":"1995","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110984_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)12022-3","article-title":"Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys","volume":"275","author":"Wiley","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110984_bb0210","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0022-3565(24)37496-8","article-title":"Structure-activity relationships of indole- and pyrrole-derived cannabinoids","volume":"285","author":"Wiley","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.11.035","article-title":"Comparison of the discriminative stimulus and response rate effects of Delta9-tetrahydrocannabinol and synthetic cannabinoids in female and male rats","volume":"172","author":"Wiley","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0220","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/7854_2016_24","article-title":"Discriminative stimulus properties of phytocannabinoids, endocannabinoids, and synthetic cannabinoids","volume":"39","author":"Wiley","year":"2018","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.110984_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110064","article-title":"Sex, species and age: effects of rodent demographics on the pharmacology of \u2206(9)-tetrahydrocanabinol","volume":"106","author":"Wiley","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110984_bb0230","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pbb.2012.06.008","article-title":"Ovarian hormones and chronic administration during adolescence modify the discriminative stimulus effects of delta-9-tetrahydrocannabinol (Delta(9)-THC) in adult female rats","volume":"102","author":"Winsauer","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"12","key":"10.1016\/j.pnpbp.2024.110984_bb0235","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1021\/ol401335u","article-title":"Total syntheses of Cannabicyclol, Clusiacyclol a and B, Iso-Eriobrucinol a and B, and Eriobrucinol","volume":"15","author":"Yeom","year":"2013","journal-title":"Org. Lett."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110984_bb0240","doi-asserted-by":"crossref","first-page":"20405","DOI":"10.1038\/s41598-020-77175-y","article-title":"In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa","volume":"10","author":"Zagzoog","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:06:35Z","timestamp":1759521995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624000526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":47,"alternative-id":["S0278584624000526"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110984","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110984"}}